Davy James, Managing Editor of Specialty Pharmacy Times

home / authors / davy-james-managing-editor-of-specialty-pharmacy-times

Articles

First Biosimilar Filgrastim Launched Today

Katie Eder, Senior Editor;Davy James, Managing Editor of Specialty Pharmacy Times

September 3rd 2015

The first biosimilar to receive FDA approval is now available the United States.

Second PCSK9 Repatha Approved by FDA

Davy James, Managing Editor of Specialty Pharmacy Times;Meghan Ross, Associate Editor

August 27th 2015

The FDA today approved evolocumab (Repatha) injection, a new treatment for patients unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

AI patient pharmacist provider interactions ASHP summer

Published: June 11th 2024 | Updated: July 27th 2024

Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions

Published: June 11th 2024 | Updated: July 27th 2024

Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications

Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com

Published: July 23rd 2024 | Updated: July 27th 2024

VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage

3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com

Published: October 18th 2023 | Updated: July 27th 2024

Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden

Published: July 23rd 2024 | Updated: July 27th 2024

Trivalent Influenza Vaccines Are Readied for Fall

Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Davy James, Managing Editor of Specialty Pharmacy Times

Articles

Latest Updated Articles